Current Issue

Application of Quality Risk Management to Process Validation

Robert Dream, Managing Director, HDR Company LLC

A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...

Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...

Ping Wang, Director, Johnson & Johnson

Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...

Amsphere A3

JSR Life Sciences



Headline News

Astellas to present 21 oncology abstracts at ESMO 2026, with long term PADCEV plus pembrolizumab bladder cancer data and zolbetuximab research in gastric cancer


Abbott’s Cologuard screening linked to fewer colorectal cancer cases and lower risk of death in new real world data


Teva’s Weltruza becomes first once monthly subcutaneous olanzapine injection to win FDA approval for adults with schizophrenia


Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

Implementation Strategies and Challenges for Single-Use Technologies at Commercial Scale

Presented by Adam Goldstein, Roche/Genentech and Jacob McNeil, Thermo Fisher Scientific
17th May 2018


Demonstrate how machine learning tools can aid development of formulation, analysis and manufacturing of pharmaceutical drug products

Presented by Erik Skibsted, Principal Scientist PhD, Novo Nordisk Denmark and Rolf Taaning, Development Specialist PhD, Novo Nordisk Denmark
08th March 2021


Rapid Microbiology Applications in the COVID-19 Era

Presented by Presented by Dr. Michael J. Miller, President of Microbiology Consultants, LLC, Ulrich Herber Director of Technology and Market Development Charles River and Lori Daane, Pharma Microbiology Scientific Director at bioMérieux
04th August 2020


View All Past Webinars

Featured Companies

 

View All Companies

© 2026 biopharma-asia.com. All rights reserved. Privacy Policy

Biopharma Asia